Sign in
4

Changes in Ownership

Seres Therapeutics, Inc. Filed Acc 0000950170-25-053247

Options or other derivatives

  • Director acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Berenson Stephen · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-04-10 Grant or award : show line 1 in the form Stock Option (right to buy) +100,000 100,000 D
Loading xslF345X05/ownership.xml…